Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Ye Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjin…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Colorectal Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing University of Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China.
Abstract (Originalsprache)
BACKGROUND: Shen-Bai-Jie-Du decoction (SBJDD), a traditional Chinese herbal formula grounded in evidence-based medicine, demonstrates efficacy in reducing the recurrence and carcinogenesis of colorectal adenoma (CRA). However, the mechanism by which SBJDD inhibits CRA carcinogenesis remains unclear. PURPOSE: This study aimed to elucidate the mechanism through which SBJDD suppresses colorectal cancer stem cell (CSC) aggressiveness by modulating the gut microbiota-bile acid (BA)-Farnesoid X receptor (FXR) signaling axis. METHODS: The APCmin/+ mouse model and subcutaneously tumor-bearing mouse model were established to investigate the efficacy and underlying mechanisms of SBJDD in CRA carcinogenesis. Multi-omics analyses were conducted using 16S rRNA, metabolomics, and transcriptome sequencing. The pharmacological effects and mechanisms of SBJDD were evaluated through RT-qPCR, immunohistochemical staining, molecular docking, Western blot, immunofluorescence staining, and flow cytometry assay. Moreover, paired fecal samples and adenoma tissues were collected from CRA patients to further validate the findings. RESULTS: Our findings demonstrated that SBJDD can protect the integrity of the intestinal mucosal barrier, thereby inhibiting colorectal tumorigenesis. Mechanistically, our study revealed that SBJDD can reduce the fecal abundance of BA-producing gut microbiota. Meanwhile, we confirmed that the BA receptor FXR and its downstream target genes were significantly upregulated following SBJDD administration, and molecular docking analyses demonstrated that the bioactive components of SBJDD can bind to FXR. Moreover, we showed that SBJDD can downregulate CSC marker genes by regulating FXR signaling pathways. CONCLUSION: Our study objectively verified that SBJDD can alleviate the malignancy of CSCs by modulating the gut microbiota-bile acid-FXR axis, ultimately suppressing the progression from colorectal adenoma to carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China; Department of…
- The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China; The first aff…
- The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- The First Clinical Medical College, Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China. Electronic ad…
Förderung
- National Natural Science Foundation of China
- Nanjing University of Chinese Medicine
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Key Research and Development Program of China
Zitieren
APA
Zhang, Y., Shen, M., Baokan, J., Xu, L., Ni, M., Jin, J., Shen, W., Sun, D., Li, L., Lai, Y., Yan, Q., Yu, C., Tan, J., Xu, C., Tao, L., Fan, M., & Cheng, H. (2025). Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157366
Vancouver
Zhang Y, Shen M, Baokan J, Xu L, Ni M, Jin J, et al. Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157366
BibTeX
@article{Zhang2025,
author = {Zhang, Ye and Shen, Meng and Baokan, Jianaer and Xu, Liting and Ni, Mingxin and Jin, Junyan and Shen, Weixing and Sun, Dongdong and Li, Liu and Lai, Yueyang and Yan, Qiuying and Yu, Chengtao and Tan, Jiani and Xu, Changliang and Tao, Lihuiping and Fan, Minmin and Cheng, Haibo},
title = {Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157366}
}
EUVIMED